Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	0.03	0.06	0.31	-
Net Debt / Equity Ratio	-0.98	-0.95	-0.82	-1.04
Net Debt / EBITDA Ratio	3.82	2.27	0.56	2.00
Net Debt / FCF Ratio	5.13	3.00	0.63	2.18
Quick Ratio	25.21	14.16	4.79	10.01
Current Ratio	25.61	14.49	4.88	10.16
Return on Equity (ROE)	-28.07%	-61.44%	-83.45%	-
Return on Assets (ROA)	-19.45%	-37.10%	-45.16%	-
Return on Capital Employed (ROCE)	-25.30%	-40.20%	-114.60%	-52.30%
Buyback Yield / Dilution	-770.59%	-31.56%	-13.80%	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q